Your browser doesn't support javascript.
loading
Phase II trial of gefitinib plus pemetrexed after relapse using first-line gefitinib in patients with non-small cell lung cancer harboring EGFR gene mutations.
Uchibori, Ken; Satouchi, Miyako; Sueoka-Aragane, Naoko; Urata, Yoshiko; Sato, Akemi; Imamura, Fumio; Inoue, Takako; Tachihara, Motoko; Kobayashi, Kazuyuki; Katakami, Nobuyuki; Kokan, Chiyuki; Hirashima, Tomonori; Iwanaga, Kentaro; Mori, Masahide; Aoe, Keisuke; Morita, Satoshi; Negoro, Shunichi.
Affiliation
  • Uchibori K; Department of Respiratory Medicine, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan.
  • Satouchi M; Division of Thoracic Oncology, Hyogo Cancer Center, 13-70, Kitaohji-cho, Akashi, Hyogo 673-8558, Japan. Electronic address: satouchi@hp.pref.hyogo.jp.
  • Sueoka-Aragane N; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, 5-1-1, Nabeshima, Saga, Saga 849-8501, Japan.
  • Urata Y; Division of Thoracic Oncology, Hyogo Cancer Center, 13-70, Kitaohji-cho, Akashi, Hyogo 673-8558, Japan.
  • Sato A; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, 5-1-1, Nabeshima, Saga, Saga 849-8501, Japan.
  • Imamura F; Department of Thoracic Oncology, Osaka International Cancer Institute, 3-1-69, Otemae, Chuo-ku, Osaka, Osaka 541-8567, Japan.
  • Inoue T; Department of Thoracic Oncology, Osaka International Cancer Institute, 3-1-69, Otemae, Chuo-ku, Osaka, Osaka 541-8567, Japan.
  • Tachihara M; Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-2, Kusunoki-cho, Chuou-ku Kobe, Hyogo 650-0017, Japan.
  • Kobayashi K; Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-2, Kusunoki-cho, Chuou-ku Kobe, Hyogo 650-0017, Japan.
  • Katakami N; Division of Medical Oncology, Kobe City Medical Center General Hospital, 2-1-1 Minatojima Minamimachi, Chuo-ku Kobe 650-0047, Japan.
  • Kokan C; Division of Medical Oncology, Kobe City Medical Center General Hospital, 2-1-1 Minatojima Minamimachi, Chuo-ku Kobe 650-0047, Japan.
  • Hirashima T; Department of Thoracic Oncology, Osaka Habikino Medical Center, 3-7-1, Habikino, Habikino, Osaka 583-8588, Japan.
  • Iwanaga K; Department of Respiratory Medicine, Saga-ken Medical Center Koseikan, 400 Nakabaru, Kase-machi, Saga, Saga 840-8571, Japan.
  • Mori M; Division of Pulmonology and Medical Oncology, Toneyama National Hospital, 5-1-1, Toneyama, Toyonaka, Osaka 560-8552, Japan.
  • Aoe K; Department of Medical Oncology, Yamaguchi-Ube Medical Center, 685 Higashikiwa, Ube, Yamaguchi 755-0241, Japan.
  • Morita S; Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine, Yoshida-Konoemachi, Sakyo-ku Kyoto, Kyoto 606-8501, Japan.
  • Negoro S; Division of Thoracic Oncology, Hyogo Cancer Center, 13-70, Kitaohji-cho, Akashi, Hyogo 673-8558, Japan.
Lung Cancer ; 124: 65-70, 2018 10.
Article de En | MEDLINE | ID: mdl-30268482
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Protocoles de polychimiothérapie antinéoplasique / Carcinome pulmonaire non à petites cellules / Pémétrexed / Géfitinib / Tumeurs du poumon / Mutation Type d'étude: Clinical_trials Limites: Aged / Aged80 / Female / Humans / Male / Middle aged Langue: En Journal: Lung Cancer Sujet du journal: NEOPLASIAS Année: 2018 Type de document: Article Pays d'affiliation: Japon Pays de publication: Irlande
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Protocoles de polychimiothérapie antinéoplasique / Carcinome pulmonaire non à petites cellules / Pémétrexed / Géfitinib / Tumeurs du poumon / Mutation Type d'étude: Clinical_trials Limites: Aged / Aged80 / Female / Humans / Male / Middle aged Langue: En Journal: Lung Cancer Sujet du journal: NEOPLASIAS Année: 2018 Type de document: Article Pays d'affiliation: Japon Pays de publication: Irlande